Clinical Trial Update: Allogeneic UCB-derived CAR-T for B-ALL [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update on an allogeneic umbilical cord blood–derived CAR-T therapy for B-cell acute lymphoblastic leukemia in early Phase 1, currently not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Allogeneic UCB-derived CAR-T therapy for B-cell acute lymphoblastic leukemia

Snippet

Sponsor: The General Hospital of Western Theater Command | Conditions: B-Cell Acute Lymphoblastic Leukemia, Adult | EARLY_Phase 1 | Status: NOT_YET_RECRUITING